NEUBASE THERAPEUTICS INC (64132K201) Institutional Ownership and Insiders Activity
NEUBASE THERAPEUTICS INC (64132K201) is widely held by institutional investors, with 1 firm reporting positions valued at approximately $100,912 based on SEC Form 13F filings for the quarter ended December 31, 2023.
Greenlight Capital is the largest disclosed holder, reporting approximately $100,912 in 64132K201 holdings in its latest filing.
Institutional ownership remains highly concentrated, with Greenlight Capital representing the majority of disclosed value.
Institutional Holders
1
Total Reported Value
$100,912
Largest Holder
Greenlight Capital
Largest Position
$100,912
Insider Transactions (90d)
0
Latest Filing Quarter
Q4 2023
New Institutional Positions
2
Funds Exiting Positions
0
Top Institutional Owners
View allInvestorReported Balance
- Greenlight Capital$100,912